PMID: 9654389Jul 8, 1998Paper

Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury

Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
E B LoucksA K Qayumi

Abstract

Reperfusion therapies for treatment of myocardial infarction successfully reduce patient mortality; however, regional myocardial ischemia-reperfusion (RMIR) causes its own expression of cardiovascular dysfunction, including myocardial depression, hemodynamic instability, and dysrhythmias, which have increased patient mortality within the first 24 h after starting reperfusion therapy. Current evidence suggests that the release of oxygen-derived reactive substances and subsequent inflammatory mediators during ischemia-reperfusion contribute toward this injury. Platelet-activating factor (PAF), a mediator released during RMIR, has been emphasized by many investigators as playing a central role in causing RMIR injury. Similar cardiovascular dysfunctions that occur during RMIR, including myocardial depression, hemodynamic instability, and dysrhythmias, occur after administration of PAF and are ameliorated with PAF antagonists. Further, PAF antagonists have been shown to be cardioprotective and improve survival when administered before onset of reperfusion. A variety of phospholipid analogues, naturally derived compounds, and synthetic compounds have been developed that form the different classes of PAF antagonists, each with unique ...Continue Reading

References

Oct 29, 1979·Biochemical and Biophysical Research Communications·M L BlankE E Muirhead
Dec 11, 1975·Journal of Molecular and Cellular Cardiology·C E Holland, R E Olson
Dec 15, 1992·Biochemical and Biophysical Research Communications·T SugimotoY Kurachi
Dec 1, 1992·Journal of Cardiovascular Pharmacology·S C BlackB R Lucchesi
Apr 1, 1992·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·A K QayumiK D Gillespie
Jun 1, 1992·Journal of Molecular and Cellular Cardiology·L L LeongR R Taylor
Dec 1, 1991·Lipids·R RabinoviciG Feuerstein
Dec 1, 1990·Clinical Science·A López-FarréJ M López-Novoa
Oct 1, 1990·Transplantation·J S Pober, R S Cotran
Aug 15, 1985·The New England Journal of Medicine·K E GrandelS I Wasserman
Jan 1, 1985·Urological Research·K M JensenP Mogensen
Nov 1, 1989·The Journal of Clinical Investigation·B M BrennerB J Ballermann
Jun 1, 1989·Journal of Applied Physiology·F R LaurindoG Z Feuerstein
May 19, 1989·European Journal of Pharmacology·M KoltaiP Braquet
Jan 1, 1987·British Journal of Pharmacology·J Casals-Stenzel, K H Weber
May 1, 1988·The Journal of Surgical Research·M J LynchM L Morganroth
Oct 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·G L StahlA M Lefer

❮ Previous
Next ❯

Citations

Jan 28, 2003·Progress in Lipid Research·Ken KarasawaMorio Setaka
Nov 18, 2000·Biochimica Et Biophysica Acta·L W Tjoelker, D M Stafforini
Sep 15, 2004·European Journal of Pharmacology·János NemcsikEva Morschl
Jun 18, 2005·Memórias do Instituto Oswaldo Cruz·Hugo C Castro Faria NetoGuy A Zimmerman
May 15, 2018·Nutrients·Alexandros TsouprasIoannis Zabetakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.